Please login to the form below

Not currently logged in
Email:
Password:

Biogen Idec names head of gene therapy

Olivier Danos joins from Kadmon Pharmaceuticals
Olivier Danos Biogen Idec

Biogen Idec has appointed Dr Olivier Danos as senior VP, gene therapy.

Dr Danos will lead Biogen Idec's gene therapy research group, a team dedicated to identifying and developing new technologies for gene transfer and genome engineering. Danos will also identify potential collaborations for the company.

“Olivier is a true pioneer in the field,” said Dr Douglas Williams, executive VP, R&D. “We believe that his expertise will help accelerate our development of a world-class gene therapy platform that combines our growing internal capabilities with collaborations with leading research organizations across the globe.”

Dr Danos joins Biogen Idec from Kadmon Pharmaceuticals, where he served as senior vice president, Molecular Medicine, Synthetic Biology and Gene Regulation since 2011.

Prior to Kadmon, Dr Danos acted as the director of the Gene Therapy Consortium of the University College of London and led a gene therapy research team at the Necker Hospital – Enfants Malades in Paris.

His career also includes a spell as president of the European Society of Gene and Cell Therapy.

24th September 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics